These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31156811)

  • 1. Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
    Klovrzová S; Zahálka L; Kříž T; Zahálková O; Matysová L; Šklubalová Z; Horák P
    Eur J Hosp Pharm; 2016 Jan; 23(1):33-37. PubMed ID: 31156811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric oral solutions with propranolol hydrochloride for extemporaneous compounding: the formulation and stability study.
    Klovrzová S; Zahálka L; Matysová L; Horák P; Sklubalová Z
    Ceska Slov Farm; 2013 Feb; 62(1):35-9. PubMed ID: 23578266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study.
    Zahálka L; Klovrzová S; Matysová L; Šklubalová Z; Solich P
    Eur J Hosp Pharm; 2018 May; 25(3):144-149. PubMed ID: 31157009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Nguyen AT; Morris TC; Graves RA
    Int J Pharm Compd; 2019; 23(2):157-162. PubMed ID: 31085781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of sotalol hydrochloride in extemporaneously prepared oral suspension formulations.
    Sidhom MB; Rivera N; Almoazen H; Taft DR; Kirschenbaum HL
    Int J Pharm Compd; 2005; 9(5):402-6. PubMed ID: 23925139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension.
    Cavelier M; Gondé H; Costa D; Lamoureux F; Pereira T; Buchbinder N; Varin R; Hervouët C
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of sotalol in two liquid formulations at two temperatures.
    Nahata MC; Morosco RS
    Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
    Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
    Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan potassium liquid formulation for paediatric hospital use: development and stability evaluation.
    Corte AC; Gobetti C; Carlos G; de Oliveira Almeida SH; Ayres MV; Steppe M; Garcia CV
    Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38724244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of hydralazine hydrochloride syrup compounded from tablets.
    Alexander KS; Pudipeddi M; Parker GA
    Am J Hosp Pharm; 1993 Apr; 50(4):683-6. PubMed ID: 8470684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA
    Int J Pharm Compd; 2021; 25(2):169-175. PubMed ID: 33798117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a gradient HPLC method for the simultaneous determination of sotalol and sorbate in oral liquid preparations using solid core stationary phase.
    Matysova L; Zahalkova O; Klovrzova S; Sklubalova Z; Solich P; Zahalka L
    J Anal Methods Chem; 2015; 2015():806736. PubMed ID: 25878920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Brandão MAF; Bauters T; De Moerloose B; Ferreira AO
    Int J Pharm Compd; 2018; 22(6):516-526. PubMed ID: 30384353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Aspects in the Preparation of Extemporaneous Flecainide Acetate Oral Solution for Paediatrics.
    Casiraghi A; Centin G; Selmin F; Picozzi C; Minghetti P; Zanon D
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA
    Int J Pharm Compd; 2020; 24(5):413-419. PubMed ID: 32886640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2021; 25(5):431-439. PubMed ID: 34623970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
    Foley L; Toney J; Barlow JW; O'Connor M; Fitzgerald-Hughes D; Ramtoola Z
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a paediatric oral formulation of clonidine hydrochloride.
    de Goede AL; Boedhram RR; Eckhardt M; Hanff LM; Koch BC; Vermaat CH; Vermes A
    Int J Pharm; 2012 Aug; 433(1-2):119-20. PubMed ID: 22580108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.